- Home
- HXHX vs RVPH Comparison
HXHX vs RVPH Comparison
Compare HXHX & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HXHX
- RVPH
- Stock Information
- Founded
- HXHX 2003
- RVPH 2006
- Country
- HXHX China
- RVPH United States
- Employees
- HXHX N/A
- RVPH N/A
- Industry
- HXHX Trucking Freight/Courier Services
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- HXHX Industrials
- RVPH Health Care
- Exchange
- HXHX Nasdaq
- RVPH Nasdaq
- Market Cap
- HXHX 36.9M
- RVPH 36.7M
- IPO Year
- HXHX 2025
- RVPH N/A
- Fundamental
- Price
- HXHX $1.45
- RVPH $0.82
- Analyst Decision
- HXHX
- RVPH Strong Buy
- Analyst Count
- HXHX 0
- RVPH 5
- Target Price
- HXHX N/A
- RVPH $10.00
- AVG Volume (30 Days)
- HXHX 244.5K
- RVPH 412.9K
- Earning Date
- HXHX 01-01-0001
- RVPH 05-15-2025
- Dividend Yield
- HXHX N/A
- RVPH N/A
- EPS Growth
- HXHX N/A
- RVPH N/A
- EPS
- HXHX 0.26
- RVPH N/A
- Revenue
- HXHX $25,571,810.00
- RVPH N/A
- Revenue This Year
- HXHX N/A
- RVPH $100.46
- Revenue Next Year
- HXHX N/A
- RVPH $49.32
- P/E Ratio
- HXHX $5.37
- RVPH N/A
- Revenue Growth
- HXHX N/A
- RVPH N/A
- 52 Week Low
- HXHX $1.35
- RVPH $0.49
- 52 Week High
- HXHX $6.29
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- HXHX N/A
- RVPH 48.25
- Support Level
- HXHX N/A
- RVPH $0.77
- Resistance Level
- HXHX N/A
- RVPH $0.90
- Average True Range (ATR)
- HXHX 0.00
- RVPH 0.07
- MACD
- HXHX 0.00
- RVPH 0.01
- Stochastic Oscillator
- HXHX 0.00
- RVPH 44.44
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.